4182:TSEMitsubishi Gas Chemical Company, Inc. Analysis
Data as of 2026-06-17 - not real-time
¥5,103.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Mitsubishi Gas Chemical (4182.T) is trading around ¥5,103, comfortably above its 20‑day SMA (~¥5,097) and the 50‑day SMA (~¥4,669), confirming a bullish price structure despite a bearish MACD histogram. The RSI sits near 55, indicating neither overbought nor oversold conditions, while the low beta of ~0.25 suggests limited market‑wide volatility, even though the 30‑day price volatility is high at roughly 65%. Recent momentum has cooled after a strong 10% three‑month rally, and the stock now hovers near a key support level of ¥4,200 with resistance around ¥5,626.
Fundamentally, the company posted a negative profit margin (-5.5%) and a trailing EPS loss, but forward EPS is projected positive, driving a forward P/E of about 18.5. The DCF fair‑value estimate of ¥2,744 is far below the current price, flagging the stock as overvalued, yet analysts maintain a “buy” consensus with a median target of ¥5,300. A dividend yield of 2.16% and a moderate payout ratio (~41%) provide income appeal, though free cash flow remains negative and debt‑to‑equity is elevated at 33, underscoring financial risk.
Fundamentally, the company posted a negative profit margin (-5.5%) and a trailing EPS loss, but forward EPS is projected positive, driving a forward P/E of about 18.5. The DCF fair‑value estimate of ¥2,744 is far below the current price, flagging the stock as overvalued, yet analysts maintain a “buy” consensus with a median target of ¥5,300. A dividend yield of 2.16% and a moderate payout ratio (~41%) provide income appeal, though free cash flow remains negative and debt‑to‑equity is elevated at 33, underscoring financial risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price consolidation near support after recent rally
- Bearish MACD histogram indicating potential pullback
- Stable volume and low beta limiting short‑term downside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Projected earnings turnaround with positive forward EPS
- Attractive dividend yield and moderate payout ratio
- Bullish trend above key moving averages and upside to resistance
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Significant valuation gap between market price and DCF fair value
- High debt level and negative free cash flow raising financial risk
- Steady dividend income and low beta supporting a defensive profile
Key Metrics & Analysis
Financial Health
Revenue Growth-0.90%
Profit Margin-5.46%
P/E Ratio18.5
ROE-4.96%
ROA2.42%
Debt/Equity33.00
P/B Ratio1.5
Op. Cash Flow¥74.7B
Free Cash Flow¥-24430125056
Technical Analysis
TrendBullish
RSI55.5
Support¥4,200.00
Resistance¥5,626.00
MA 20¥5,097.30
MA 50¥4,668.74
MA 200¥3,520.86
MACDBearish
VolumeStable
Fear & Greed Index92.13
Valuation
Fair Value¥2,743.83
Target Price¥5,060.00
Upside/Downside-0.84%
GradeOvervalued
TypeBlend
Dividend Yield2.16%
Risk Assessment
Beta0.25
Volatility65.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.